Compounds Targeting Inflammatory Protein to Treat MS Focus of Study – Multiple Sclerosis News Today

A search is on for an anti-inflammatory treatment targeting the C-reactive protein — CRP, a biomarker of inflammation produced by the liver — of possible use in a wide variety of conditions, including immune-mediated diseases such as multiple sclerosis (MS).

Researchers at the Baker Heart and Diabetes Institute and the University of Melbourne, both in Australia, are working to find compounds that target CRP and may ease the inflammatory reaction its overproduction can provoke.

Read more at: https://multiplesclerosisnewstoday.com/news-posts/2020/10/12/compounds-targeting-inflammatory-c-reactive-protein-crp-under-study-australia/

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize